A New York University research team is using hallucinogenic experiences to help patients come to terms with their mortality.by Roc Morin“‘Some of the things I’m about to say might not make sense,’ began O.M., a 22-year-old cancer survivor. He had the far-off look in his...
Abstract This essay describes the founding of the Heffter Research Institute in 1993 and its development up to the present. The Institute is the only scientific research organization dedicated to scientific research into the medical value of psychedelics, and it has particularly focused on the use...
At the Psychedelic Science 2013 conference held in Oakland, CA in April 2013, Heffter founder Dave Nichols and Heffter Zurich researcher Franz Vollenweider presented this in-depth workshop focusing on the latest advances in scientific understanding of how psychedelic compounds affect the brain. Dave starts the workshop...
The Heffter Research Institute celebrates its 20th anniversary in November 2013. In those 20 years we have provided nearly $4 million in support of the following research programs: Use of psilocybin in obsessive compulsive disorder (Dr. Francisco Moreno at the University of Arizona) Psilocybin in...
Teri S. Krebs and Pål-Ørjan JohansenABSTRACTBackgroundThe classical serotonergic psychedelics LSD, psilocybin, mescaline are not known to cause brain damage and are regarded as non-addictive. Clinical studies do not suggest that psychedelics cause long-term mental health problems. Psychedelics have been used in the Americas for thousands...
by Scott HensleyHow risky are psychedelic drugs to mental health? Not nearly as much as you might have imagined.People who had taken LSD, psilocybin (the brain-bending chemical in magic mushrooms) or mescaline at any time in their lives were no more likely than those who...
Research into mind-altering drugs is back. By Zoë CorbynYou don’t have to spend much time at the six-day second international Psychedelic Science conference in downtown Oakland to learn that not all its 1,900 attendees are academic scientists, and that few are strangers to the power...
By Dan OlsonST. PAUL, Minn. — To the untrained eye, a certain greenhouse of plants at the University of Minnesota’s St. Paul campus may seem like nothing special. But Dennis McKenna, an ethno-pharmacologist, sees much more than that.Some can cure disease, like the Madagascar periwinkle.“It...
Psilocybin, the active ingredient in magic mushrooms, is being explored as a therapeutic tool to improve the lives of people with a life-threatening illness. By Erica RexThis article was originally published with the title Calming a Turbulent Mind.Link to PREVIEW of article | Scientific American...
Once taboo, psychedelics are making an enlightening medical comebackby Jennifer Bleyer / GSAS ’12On a spring day in 2010, “Sandra,†then a 63-year-old ice-skating instructor with short graying hair and an impish smile, received her diagnosis: ovarian cancer, stage 1C. The rock-hard tumor growing inside...
